申请人:Eatherton Andrew John
公开号:US20090018128A1
公开(公告)日:2009-01-15
The present invention relates to novel pyrrolopyrazine derivatives, pharmaceutical compositions containing these compounds and their use in the treatment of diseases, particularly pain, which diseases are caused directly or indirectly by an increase or decrease in activity of the cannabinoid receptor.
本发明涉及新型吡咯吡嗪衍生物、含有这些化合物的制药组合物以及它们在治疗疾病中的应用,特别是直接或间接由大麻素受体活性的增加或减少引起的疼痛。